the formal research studies conducted by its manufacturer glaxosmithkline showed that: (a) it had no value in acute mania (b) it had some modest value in bipolar depression especially if more severe but not treatment-resistant (c) it prevented depressions and manias but did a better job preventing depressions than manias (d) it worked better in bipolar i than bipolar ii and (e) it had no clear benefit for anxiety symptoms. apart from the risk of rash (related to rapid dosing) it also appears to have few side effects and is weight neutral.
what can you expect if you use lamictal to treat bipolar disorder?